Q1 FY27: Standalone loss at Rs 51L, consolidated PAT drops to Rs 199L
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Health X Platform (formerly Sastasundar Ventures) posted Q1 FY27 results. Consolidated revenue rose about 50 percent YoY to Rs 44,685 lakhs, but net profit fell sharply to Rs 198.67 lakhs from Rs 2,659 lakhs last year. Exceptional items of about Rs 96 lakhs hurt earnings. Standalone entity reported a loss of Rs 51.43 lakhs. Auditor flagged going concern uncertainty at step-down subsidiary Genu Path Labs whose net worth is fully eroded.
Mixed signals: strong revenue growth but sharp profit fall. Going concern flag at subsidiary Genu Path Labs is a concern worth monitoring.